Please login to the form below

Not currently logged in
Email:
Password:

Bluebird Bio reveals further encouraging data for CALD gene therapy

Bluebird BioStudy shows continued benefit in treatment of rare disease

Takeda’s HAE drug Takhzyro backed by NICE

New treatment option for rare, hereditary disease

Distribution of Novartis’ generic Zantac halted due to carcinogen concerns

Sandoz NovartisRanitidine medicines found to contain cancer-causing substance

Roche wins FDA breakthrough for Gazyva in lupus nephritis

Roche - Basel, SwitzerlandDrug originally approved as a lymphoma treatment

Zenopa delivers Communiqué prizes to winners

Zenopa winner 2Publicis Resolute's Georgina Chan, MGP's Peter Sayer and Celgene's Sara Jones win the prizes

Biogen loses another pipeline drug to toxicity concerns

BiogenFollows discontinuation of Eisai-partnered Alzheimer's drug

FDA starts speedy review of Merck’s Ebola vaccine

First company to file for approval in the US

Purdue Pharma files for bankruptcy after opioid settlement

purdue pharma logoCompany has faced brunt of blame for fuelling epidemic

Jessica Pacey 2Q&A: Jessica Pacey

PME interviews the founder and chief executive of newly launched health comms agency, 67health

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics